Treatment of gingival overgrowth induced by manidipine administration. A case report

Journal of Periodontology

Volumn 73, Issue 1, 2002, Pages 115-122

  Ikawa, Kyoko ^a   Ikawa, Motohide ^a   Shimauchi, Hidetoshi ^a   Iwakura, Masaki ^a   Sakamoto, Seizaburo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Calcium channel blockers; Dental plaque prevention and control; Gingival hyperplasia etiology; Gingival index; Periodontal index; Periodontal probes; Sj gren's syndrome

Indexed keywords

AROTINOLOL; BISOPROLOL FUMARATE; BROMHEXINE; CALCIUM CHANNEL BLOCKING AGENT; CARTEOLOL; MANIDIPINE; NIFEDIPINE;

ADULT; ANGINA PECTORIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; GINGIVA BLEEDING; GINGIVA OVERGROWTH; GINGIVECTOMY; HISTOLOGY; HUMAN; HYPERTENSION; LOCAL ANESTHESIA; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; MOUTH HYGIENE; PREVENTIVE DENTISTRY; SALIVATION; SJOEGREN SYNDROME; TOOTH OCCLUSION; TOOTH PLAQUE; TOOTH PROSTHESIS; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DENTAL PLAQUE INDEX; DENTAL SCALING; DENTURE, PARTIAL, FIXED; DIHYDROPYRIDINES; FEMALE; GINGIVAL OVERGROWTH; GINGIVECTOMY; HUMANS; HYPERTENSION; ORAL HYGIENE; PERIODONTAL INDEX; PERIODONTAL POCKET; ROOT PLANING; SALIVA; SJOGREN'S SYNDROME;

EID: 0036200838     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2002.73.1.115     Document Type: Article

References (49)

1. Medication induced gingival overgrowth
2. The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts
3. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
4. Management of patients with chronic stable angina at low risk for serious cardiac events
5. Third generation calcium entry blockers
6. A comparative review of the adverse effects of calcium antagonists
7. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
8. Gingival hyperplasia associated with nifedipine therapy. Report of a case
9. Gingival hyperplasia caused by nifedipine-a preliminary report
10. Verapamil-induced gingival overgrowth: A clinical, histologic, and biochemic approach
11. Incidence of verapamil-induced gingival hyperplasia in a dental population
12. Cardizem induced gingival hyperplasia: A report of two cases
13. Gingival overgrowth induced by diltiazem. A case report
14. Gingival hyperplasia: A side effect of nifedipine and diltiazem
15. Nitrendipine-induced gingival hyperplasia. First case report
16. Felodipine-induced gingival hyperplasia: A clinical and histologic study
17. Severe mucosal hyperplasia of the edentulous maxilla associated with immunosuppressant therapy: A clinical report
18. Gingival hyperplasia in dogs induced by oxodipine, a calcium channel blocking agent
19. Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth
20. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine
21. Effect of manidipine, a novel calcium channel blocker, on quality of life in hypertensive patients
22. Clinical evaluation of the efficacy and safety of manidipine in hypertensive patients with renal disorders
23. Sjögren's syndrome
24. Periodontal status and serum antibody responses to oral microorganisms in Sjögren's syndrome
25. Prevalence of periodontal disease in patients with Sjögren's syndrome
26. Caries and periodontal conditions in patients with primary Sjögren's syndrome
27. The plaque control record
28. Probing force and the relationship of the probe tip to the periodontal tissues
29. Incidence of diphenylhydantoin gingival hyperplasia
30. Alveolar bone loss as related to oral hygiene and age
31. Immunizing both hard and soft mouth tissue to infection by correct stimulation with the toothbrush
32. The incidence and severity of nifedipine-induced gingival overgrowth
33. Clinical assessment of gingival hyperplasia in patients treated with nifedipine
34. Clinical assessment of gingival size among patients treated with diltiazem
35. Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem
36. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth
37. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists
38. Iatrogenic gingival overgrowth in cardiac transplantation
39. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study
40. Risk factors for drug-induced gingival overgrowth
41. Gingival hyperplasia caused by nifedipine. Histopathologic findings
42. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study
43. Nifedipine-induced gingival hyperplasia
44. Subgingival microflora associated with nifedipine-induced gingival overgrowth
45. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model
46. Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque
47. Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: Gingivectomy versus periodontal flap
48. Periodontal mechanoreceptors and parotid secretion in animals and man
49. Association of salivary flow rates with maximal bite force